MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

Inicio・Lista de Acciones・Lisata Therapeutics

L
Lisata Therapeutics

Cerrado

2.13 -0.47

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.13

Máximo

2.13

Métricas clave
By Trading Economics
Empleados	26

Dividendos
By Dow Jones
Próximas Ganancias	26 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-4.6M 16M
Apertura anterior	2.6
Cierre anterior	2.13

Lisata Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

19 ene 2026, 16:17 UTC

Adquisiciones, fusiones, absorciones

Zurich Insurance Makes $10 Billion Bid for U.K. Specialist Insurer Beazley -- Update

19 ene 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Europe Relations -- Market Talk

19 ene 2026, 23:42 UTC

Charlas de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

19 ene 2026, 22:29 UTC

Charlas de Mercado

China Infant Formula Market May Hold Up Despite Steep Drop in Births -- Market Talk

19 ene 2026, 22:29 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

19 ene 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

19 ene 2026, 21:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

19 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

19 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

19 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

19 ene 2026, 17:09 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

19 ene 2026, 17:09 UTC

Charlas de Mercado

Copper Rises in Spite of Softer Dollar, Trade Concerns -- Market Talk

19 ene 2026, 16:18 UTC

Charlas de Mercado

New Zealand Dollar Could Recover Against Swedish Krona -- Market Talk

19 ene 2026, 16:12 UTC

Charlas de Mercado

Norwegian Krone's Recent Gains Are Unlikely to Last -- Market Talk

19 ene 2026, 16:06 UTC

Adquisiciones, fusiones, absorciones

LVMH: Deal Completion Subject to Customary Closing Conditions and Expected to Close in Around Two Months

19 ene 2026, 16:04 UTC

Adquisiciones, fusiones, absorciones

LVMH: Both Parties Aim to Set Up Strategic Cooperation in the Retail Sector

19 ene 2026, 16:03 UTC

Adquisiciones, fusiones, absorciones

LVMH, CTG Duty-Free Also Entered Into a MoU

19 ene 2026, 16:02 UTC

Adquisiciones, fusiones, absorciones

LVMH: Subscription to Be Made Upon Completion of Transaction

19 ene 2026, 16:00 UTC

Adquisiciones, fusiones, absorciones

LVMH: Capital Increase by Subscribing to Newly Issued H-shares Listed in Hong Kong

19 ene 2026, 16:00 UTC

Charlas de Mercado

Term Premium on U.S. Treasurys Looks Too Low, Says Pictet AM -- Market Talk

19 ene 2026, 15:58 UTC

Adquisiciones, fusiones, absorciones

LVMH and the Miller Family Will Participate in a Capital Increase of CTG DutyFree

19 ene 2026, 15:57 UTC

Adquisiciones, fusiones, absorciones

LVMH: DFS Will Continue to Operate Its Other Luxury Travel Retail Operations Worldwide

19 ene 2026, 15:57 UTC

Adquisiciones, fusiones, absorciones

LVMH: Proceeds of Transaction Will Be Paid in Cash

19 ene 2026, 15:56 UTC

Adquisiciones, fusiones, absorciones

LVMH: CTG Duty-Free Will Run the Acquisition Through Its Subsidiary China Duty Free International Limited

19 ene 2026, 15:53 UTC

Adquisiciones, fusiones, absorciones

LVMH: Intangible Assets Include a Series of DFS Brands and IP for Exclusive Use in Greater China

19 ene 2026, 15:52 UTC

Adquisiciones, fusiones, absorciones

LVMH: CTG Duty-Free to Acquire the DFS Retail Stores in Hong Kong and Macau and Intangible Assets

19 ene 2026, 15:51 UTC

Adquisiciones, fusiones, absorciones

LVMH: DFS, CTG Duty-Free Reach Definitive Pact for CTG Duty-Free to Buy DFS' Travel Retail Unit in Hong Kong and Macau and Intangible Assets in Greater China

19 ene 2026, 15:39 UTC

Charlas de Mercado

Canadian Dollar's Underperformance Looks Overstretched -- Market Talk

19 ene 2026, 15:37 UTC

Charlas de Mercado

Bank of Canada Could Consider Cutting Rates if Underlying Inflation Slows Further -- Market Talk

Comparación entre iguales

Cambio de precio

Lisata Therapeutics Esperado

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Lisata Therapeutics Dist en los últimos 3 meses.

Finanzas

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.